Ralliant Corporation $RAL Shares Acquired by Teacher Retirement System of Texas

Teacher Retirement System of Texas increased its position in Ralliant Corporation (NYSE:RALFree Report) by 6.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 570,878 shares of the company’s stock after buying an additional 36,800 shares during the period. Teacher Retirement System of Texas owned about 0.51% of Ralliant worth $29,063,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Phocas Financial Corp. grew its holdings in Ralliant by 81.2% in the fourth quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock valued at $7,999,000 after purchasing an additional 70,403 shares during the period. Vanguard Group Inc. grew its holdings in Ralliant by 10.7% in the third quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after purchasing an additional 1,415,327 shares during the period. Welch & Forbes LLC purchased a new stake in Ralliant in the third quarter valued at approximately $854,000. SG Capital Management LLC purchased a new stake in Ralliant in the third quarter valued at approximately $8,139,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in Ralliant by 5,269.9% in the third quarter. Allspring Global Investments Holdings LLC now owns 317,038 shares of the company’s stock valued at $14,000,000 after purchasing an additional 311,134 shares during the period.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Barclays lowered their target price on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating for the company in a report on Monday, February 9th. Oppenheimer lowered their target price on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Citigroup lowered their target price on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a report on Friday, February 6th. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price for the company in a report on Friday, February 6th. Finally, Royal Bank Of Canada lowered their target price on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $50.50.

Get Our Latest Research Report on Ralliant

Insider Activity

In other news, SVP Amir A. Kazmi acquired 2,545 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were bought at an average price of $39.27 per share, for a total transaction of $99,942.15. Following the completion of the purchase, the senior vice president directly owned 39,699 shares of the company’s stock, valued at approximately $1,558,979.73. This trade represents a 6.85% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Anelise Angelino Sacks acquired 2,000 shares of the company’s stock in a transaction dated Monday, February 9th. The shares were purchased at an average price of $41.25 per share, for a total transaction of $82,500.00. Following the purchase, the director directly owned 5,403 shares of the company’s stock, valued at approximately $222,873.75. This trade represents a 58.77% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 8,145 shares of company stock valued at $332,233 over the last quarter.

Ralliant Trading Up 0.4%

Shares of RAL stock opened at $45.41 on Friday. The stock has a market cap of $5.08 billion and a price-to-earnings ratio of 23.17. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $57.02. The firm’s 50 day moving average price is $44.06 and its two-hundred day moving average price is $46.82.

Ralliant (NYSE:RALGet Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. The firm’s revenue for the quarter was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS. On average, analysts anticipate that Ralliant Corporation will post 2.37 EPS for the current year.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 23rd. Shareholders of record on Monday, March 9th were given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Monday, March 9th. Ralliant’s payout ratio is 10.20%.

Ralliant Company Profile

(Free Report)

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

Featured Articles

Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RALFree Report).

Institutional Ownership by Quarter for Ralliant (NYSE:RAL)

Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.